FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097548061> ?p ?o ?g. }

• W2097548061 endingPage "274" @default.
• W2097548061 startingPage "268" @default.
• W2097548061 abstract "Aims: Bosentan is efficacious in idiopathic pulmonary arterial hypertension, and the variants associated with connective tissue disease, but not currently approved for treatment of pulmonary arterial hypertension due to Eisenmenger's syndrome. We sought to evaluate its effect in adults with Eisenmenger's syndrome. Methods: We administered bosentan on the basis of compassionate use in 23 patients with Eisenmenger's syndrome, aged 37 plus or minus 14 years. Of the patients, 17 had never received specific treatment for pulmonary arterial hypertension, five were transitioned from treprostinil, and one from beraprost to bosentan. We measured functional class, saturation of oxygen, haemoglobin levels and six-minute walk distance at baseline, one, six months and at most recent follow-up. Results: Baseline functional class was IV in three, III in fifteen, and II in five patients. At follow-up, with a mean of 15 plus or minus 10 months, 13 of the 23 patients (57%) had improved by at least one functional class, from a median baseline of III to II (p equal to 0.016), mean saturation of oxygen at rest had increased from 81% to 84% (p equal to 0.001), and levels of haemoglobin had decreased from 178 plus or minus 26 grams per litre to 167 plus or minus 19 grams per litre (p equal to 0.001). Overall, the six-minute walk distance did not change from baseline of 335 metres. The distance walked by those not previously receiving specific therapy, however, improved from 318 plus or minus 129 to 345 plus or minus 123 metres (p equal to 0.03). Conclusion: Treatment of adults with Eisenmenger's syndrome using bosentan significantly improved functional class, saturation of oxygen at rest, and decreased levels of haemoglobin. Treatment with bosentan was associated with improvement in six-minute walk distance in those not previously receiving specific therapy. In patients already in receipt of specific therapy, transition to bosentan resulted in no clinical deterioration." @default.
• W2097548061 created "2016-06-24" @default.
• W2097548061 creator A5020670867 @default.
• W2097548061 creator A5030081847 @default.
• W2097548061 creator A5048107938 @default.
• W2097548061 creator A5073502710 @default.
• W2097548061 creator A5074386122 @default.
• W2097548061 creator A5084018393 @default.
• W2097548061 creator A5091095814 @default.
• W2097548061 creator A5091151702 @default.
• W2097548061 date "2006-05-26" @default.
• W2097548061 modified "2023-09-30" @default.
• W2097548061 title "Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease" @default.
• W2097548061 cites W1527781633 @default.
• W2097548061 cites W1840736932 @default.
• W2097548061 cites W1974227996 @default.
• W2097548061 cites W1985421372 @default.
• W2097548061 cites W1994219663 @default.
• W2097548061 cites W2025252445 @default.
• W2097548061 cites W2025344305 @default.
• W2097548061 cites W2027267084 @default.
• W2097548061 cites W2028042984 @default.
• W2097548061 cites W2029190119 @default.
• W2097548061 cites W2037260910 @default.
• W2097548061 cites W2039688899 @default.
• W2097548061 cites W2041151644 @default.
• W2097548061 cites W2048443661 @default.
• W2097548061 cites W2059983659 @default.
• W2097548061 cites W2062075871 @default.
• W2097548061 cites W2067115616 @default.
• W2097548061 cites W2076196308 @default.
• W2097548061 cites W2094601195 @default.
• W2097548061 cites W2101386214 @default.
• W2097548061 cites W2102344094 @default.
• W2097548061 cites W2103058477 @default.
• W2097548061 cites W2105116729 @default.
• W2097548061 cites W2138649273 @default.
• W2097548061 cites W2150989458 @default.
• W2097548061 cites W2270579875 @default.
• W2097548061 cites W2322334059 @default.
• W2097548061 cites W2333496742 @default.
• W2097548061 doi "https://doi.org/10.1017/s1047951106000114" @default.
• W2097548061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16725066" @default.
• W2097548061 hasPublicationYear "2006" @default.
• W2097548061 type Work @default.
• W2097548061 sameAs 2097548061 @default.
• W2097548061 citedByCount "26" @default.
• W2097548061 countsByYear W20975480612012 @default.
• W2097548061 countsByYear W20975480612013 @default.
• W2097548061 countsByYear W20975480612014 @default.
• W2097548061 countsByYear W20975480612015 @default.
• W2097548061 countsByYear W20975480612016 @default.
• W2097548061 countsByYear W20975480612017 @default.
• W2097548061 countsByYear W20975480612018 @default.
• W2097548061 countsByYear W20975480612020 @default.
• W2097548061 countsByYear W20975480612021 @default.
• W2097548061 countsByYear W20975480612022 @default.
• W2097548061 crossrefType "journal-article" @default.
• W2097548061 hasAuthorship W2097548061A5020670867 @default.
• W2097548061 hasAuthorship W2097548061A5030081847 @default.
• W2097548061 hasAuthorship W2097548061A5048107938 @default.
• W2097548061 hasAuthorship W2097548061A5073502710 @default.
• W2097548061 hasAuthorship W2097548061A5074386122 @default.
• W2097548061 hasAuthorship W2097548061A5084018393 @default.
• W2097548061 hasAuthorship W2097548061A5091095814 @default.
• W2097548061 hasAuthorship W2097548061A5091151702 @default.
• W2097548061 hasConcept C126322002 @default.
• W2097548061 hasConcept C144980905 @default.
• W2097548061 hasConcept C164705383 @default.
• W2097548061 hasConcept C170493617 @default.
• W2097548061 hasConcept C2776432619 @default.
• W2097548061 hasConcept C2779249879 @default.
• W2097548061 hasConcept C2780930700 @default.
• W2097548061 hasConcept C2781109936 @default.
• W2097548061 hasConcept C71924100 @default.
• W2097548061 hasConceptScore W2097548061C126322002 @default.
• W2097548061 hasConceptScore W2097548061C144980905 @default.
• W2097548061 hasConceptScore W2097548061C164705383 @default.
• W2097548061 hasConceptScore W2097548061C170493617 @default.
• W2097548061 hasConceptScore W2097548061C2776432619 @default.
• W2097548061 hasConceptScore W2097548061C2779249879 @default.
• W2097548061 hasConceptScore W2097548061C2780930700 @default.
• W2097548061 hasConceptScore W2097548061C2781109936 @default.
• W2097548061 hasConceptScore W2097548061C71924100 @default.
• W2097548061 hasIssue "3" @default.
• W2097548061 hasLocation W20975480611 @default.
• W2097548061 hasLocation W20975480612 @default.
• W2097548061 hasOpenAccess W2097548061 @default.
• W2097548061 hasPrimaryLocation W20975480611 @default.
• W2097548061 hasRelatedWork W1932958396 @default.
• W2097548061 hasRelatedWork W1988329185 @default.
• W2097548061 hasRelatedWork W2057297946 @default.
• W2097548061 hasRelatedWork W2097548061 @default.
• W2097548061 hasRelatedWork W2156532059 @default.
• W2097548061 hasRelatedWork W2187057984 @default.
• W2097548061 hasRelatedWork W2282055220 @default.
• W2097548061 hasRelatedWork W2313022929 @default.
• W2097548061 hasRelatedWork W3075620377 @default.

• next